CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer

被引：0
|
作者：
Asim Pervaiz
Michael Zepp
Saqib Mahmood
Doaa Mohamed Ali
Martin R. Berger
Hassan Adwan
机构：
[1] University of Health Sciences,Institute of Biomedical and Allied Health Sciences
[2] Toxicology and Chemotherapy Unit,undefined
[3] German Cancer Research Centre (DKFZ),undefined
[4] German University of Cairo,undefined
来源：
Cellular Oncology | 2019年 / 42卷
关键词：
Breast cancer; Bone metastasis; CCR5; Maraviroc; Cell cycle arrest; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：93 / 106
页数：13
相关论文
共 50 条
  • [1] CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
    Pervaiz, Asim
    Zepp, Michael
    Mahmood, Saqib
    Ali, Doaa Mohamed
    Berger, Martin R.
    Adwan, Hassan
    CELLULAR ONCOLOGY, 2019, 42 (01) : 93 - 106
  • [2] Therapeutic potential of blocking CCR5 by maraviroc in breast cancer bone metastasis
    Pervaiz, Asim
    Zepp, Michael
    Ali, Doaa M.
    Berger, Martin R.
    Adwan, Hassan
    CANCER RESEARCH, 2016, 76
  • [3] Inhibition and blockage of CCR5: A possible therapeutic option for colorectal cancer
    Pervaiz, A.
    Berger, M. R.
    Adwan, H.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 44 - 44
  • [4] CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells
    Asim Pervaiz
    Shariq Ansari
    Martin R. Berger
    Hassan Adwan
    Medical Oncology, 2015, 32
  • [5] CCR5 blockage by maraviroc induces cytotoxic and apoptotic effects in colorectal cancer cells
    Pervaiz, Asim
    Ansari, Shariq
    Berger, Martin R.
    Adwan, Hassan
    MEDICAL ONCOLOGY, 2015, 32 (05)
  • [6] CCR5 is a potential therapeutic target for cancer
    Hemmatazad, Hossein
    Berger, Martin D.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (04) : 311 - 327
  • [7] CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination
    Mencarelli, Andrea
    Graziosi, Luigina
    Renga, Barbara
    Cipriani, Sabrina
    D'Amore, Claudio
    Francisci, Daniela
    Bruno, Angela
    Baldelli, Franco
    Donini, Annibale
    Fiorucci, Stefano
    TRANSLATIONAL ONCOLOGY, 2013, 6 (06) : 784 - 793
  • [8] The Role and Therapeutic Targeting of CCR5 in Breast Cancer
    Hamid, Rasha
    Alaziz, Mustafa
    Mahal, Amanpreet S.
    Ashton, Anthony W.
    Halama, Niels
    Jaeger, Dirk
    Jiao, Xuanmao
    Pestell, Richard G.
    CELLS, 2023, 12 (18)
  • [9] Maraviroc: a new CCR5 antagonist
    Sayana, Shilpa
    Khanlou, Homayoon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (01) : 9 - 19
  • [10] Secondary effects of treatment with maraviroc and other CCR5 antagonists. Potential impact of the CCR5 blocker
    Arribas Lopez, Jose R.
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2008, 26 : 23 - 27
12345